Aurogra: Potency in Pharmacology

Svitlana Harkusha
Posted by Svitlana Harkusha August 31, 2024
Feature Details
Active Ingredient Sildenafil Citrate
Available Dosage 100 mg
Formulation Tablet
Onset of Action 30-60 minutes
Duration Up to 4 hours
Manufacturer Aurochem Laboratories
Visit Aurogra Official Site

The utilization of Aurogra in addressing erectile dysfunction unveils significant pharmacological dynamics. Its active compound, Sildenafil Citrate, exhibits a profound interaction within the human body. Upon administration, absorption transpires in the gastrointestinal tract. Peak plasma concentrations manifest within 30 to 120 minutes post-ingestion. The agent, primarily metabolized by hepatic enzymes CYP3A4 and CYP2C9, reveals a half-life of 3 to 5 hours. Excretion is largely renal and fecal.

Precise Dosage Information

Administering Aurogra 100 mg should align with therapeutic directives. A single dose, preceding sexual activity by an hour, suffices for most cases. Exceeding one dose within 24 hours is ill-advised. Tablet intake with water optimizes absorption. Variations in dosage might occur based on individual response and health status. Patients with hepatic impairment may require dosage adjustments. Adherence to prescribed regimens ensures efficacy and minimizes adverse effects.

Critical Aurogra Contraindications

Aurogra consumption presents contraindications that warrant careful consideration. Patients with hypersensitivity to Sildenafil or any tablet component should avoid usage. Concurrent administration with nitrates poses a significant risk of hypotension. Individuals with severe cardiovascular disorders, including recent myocardial infarction or stroke, should refrain. Other contraindications include severe hepatic impairment, retinal disorders, and hereditary degenerative retinal diseases.

Potential Drug Interactions and Cautions

Interaction with other medications can amplify or mitigate Aurogra 100 mg effects. Concurrent use with alpha-blockers may result in symptomatic hypotension. Caution is advised with potent CYP3A4 inhibitors such as ketoconazole or ritonavir. Coadministration with other erectile dysfunction treatments should be avoided. Grapefruit juice may alter Sildenafil metabolism. Patient history of priapism or anatomical penile deformities necessitates precaution.

Toxicological Concerns

Toxicity associated with Aurogra arises from excessive intake. Overdose may manifest as severe adverse reactions including hypotension, syncope, or priapism. Immediate medical intervention is crucial in such scenarios. Supportive care and symptomatic treatment remain the mainstay of management. Monitoring and adherence to dosage limits prevent potential toxicological events.

Availability Over the Counter

Aurogra availability over the counter remains restricted in many regions. Prescription-based access ensures that patient safety is prioritized. Regulatory oversight aims to prevent misuse and ensure proper indication. Direct purchase without a medical assessment might lead to inappropriate use and complications. Consultation with healthcare professionals aids in optimal and safe utilization of the medication.

Aurogra demonstrates substantial efficacy in the realm of erectile dysfunction treatment. Its pharmacokinetic profile and structured dosage approach facilitate its widespread use. Adhering to contraindications and considering potential interactions enhance safety. Though not readily available over the counter, its prescription use underlines a commitment to therapeutic efficacy and patient safety.

Information taken from: